Implementing Screening for Nonalcoholic Fatty Liver Disease in Endocrinology Clinics

Journal Article (Journal Article)

Nonalcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes (T2D) remains underrecognized by health care providers. The primary purpose of this quality improvement project was to increase identification of NAFLD among patients with T2D followed in an endocrinology practice using an evidence-based algorithm to risk stratify patients. Pre- and post-intervention analysis revealed a significant 36% increase in screening for NAFLD post-intervention (P < 0.001).

Full Text

Duke Authors

Cited Authors

  • Piercy, DL; Kreider, KE; Coviello, A; Patel, YA; Thompson, JA

Published Date

  • January 1, 2022

Published In

International Standard Serial Number (ISSN)

  • 1555-4155

Digital Object Identifier (DOI)

  • 10.1016/j.nurpra.2022.10.012

Citation Source

  • Scopus